Analysis

Life Sciences and Healthcare team M&A performance

Continued success in advising our clients globally

Deloitte is a leading, global adviser in the Life Sciences and Healthcare sector providing a dedicated corporate finance advisory service, with an excellent track record of success, driven by strong industry knowledge.

We are proud to have advised on over 50 completed deals during the last twelve months across our global Life Sciences and Healthcare M&A practice, and to be recognised by Mergermarket as the leading Financial Advisor globally in the sector.

We look forward to continuing to make a positive impact in the lives of patients by helping to build the Life Sciences and Healthcare companies of the future.
 

Key highlights:

# 1 Financial Adviser in EMEA Life Sciences and Healthcare M&A (H1 2019) (Mergermarket)

# 1 Financial Adviser in EMEA Life Sciences and Healthcare M&A (2018) (Mergermarket)

  • 51 transactions completed in the last twelve months
  • £1.8bn total Enterprise Value
  • 180+ advisers operating across 30+ countries

The Life Sciences and Healthcare M&A team is part of Deloitte Corporate Finance, one of the largest M&A advisors globally, consisting of over 2,500 M&A professionals advising on over 500 deals per year.

Did you find this useful?